2006, Number 1
<< Back Next >>
Gac Med Mex 2006; 142 (1)
2470insG, representsthe commonest mutation in mexican patients with dystrophic bullous epidermolysis. A study of 21 families.
Salas-Alanis JC, McGrath JA
Language: Spanish
References: 20
Page: 29-34
PDF size: 574.65 Kb.
ABSTRACT
Background: Type VII collagen gene (COL 7 Al) mutations are the cause of dystrophic epidermolysis bullosa (DEB), but most mutations are specific to individual families and there is limited data on the nature of COL 7 Al mutations in certain ethnic populations.
Objective: To determine the molecular basis of DEB in Mexican patients and describe the most frequent mutation among this ethnic population.
Methods: Most subjects were approached at FUNDACION DEBRA MEXICO AC. Molecular analysis was performed by polymerase chain reaction (PCR) of genomic DNA using COL 7 A l-specific primers, heteroduplex analysis, and direct nucleotide sequencing.
Results: Fifty nine of 67 COL 7 Al possible mutations (88%) were identified; 36 individuals (31 recessive, five dominant) from 21 families. Recessive mutations included six frameshift mutations, four silent glycine substitutions and two splice site mutations.
Conclusions: The present study informs a different kind of mutation observed in our patient population. Only two mutations informed in this study had been described earlier among another ethnic group. The most frequent mutation was 2470insG, affecting 21(58.3%) out of 36 patients with DEB. These new data will be helpful in facilitating the accurate diagnosis of an DEB subtype, and will add further insight into the pathophysiology of this mechanobullous disease.
REFERENCES
Arenas R. Dermatología, Atlas, diagnóstico y tratamiento, segunda edición Interamericana McGraw-Hill 1999;123-150.
Fine JD, Bauer EA, Briggaman RA et al. Epidermolysis Bullosa. Application of epidemiologic principIes to the study of a group of rare disease via a disease registry. Dermatol Clinics 1995; 13:659-670. Revised clinical and laboratory criteria for subtypes of epidermolysis bullosa. A consensus report by the subcommittee on Diagnosis and Classification of the National Epidermolysis Bullosa Registry. J Am Acad Dermatol 1991;24:119-135.
Fine JD, Eady RAJ, Bauer EA, Briggaman RA, Bruckmer-Tuderman L, Christiano AM, et al. Revised classification system for inherited epidermolysis bullosa: Report of the second International consensus meeting on diagnosis and classification of epidermolysis bullosa. J Am Acad Dermatol 2000;42:1051-66.
Giles SM, Mcgrath JA, Richards AJ, Christiano AM, Uitto J, Michael Pope F, Lady JA. Clinicopathological Correlations of Compound Heterozygous COL 7 Al Mutations in Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatol 1996;107: 171-177.
Heagerty AHM, Kennedy AR, Leigh M, Purkis P, Lady RAJ. Identification of epidermal basement membrane defect in recessive dystrophic epidermolyisis bullosa by LH7-2 monoclonal antibody: use in diagnosis. Br J Dermatol 1986;115:125-131.
Christiano AM, Greenspan DS, Hoffman GC et al. A non sense mutationin type VII collagen in two affected siblings with recessive dystrophic epidermolysis bullosa. Nat Genet 1993;4:62-66.
Mellerio JE, Giles SM, Allison W, Ashton GH, Christiano AM, Uitto J, Eady RA McGrath JA. Recurrent mutations in the Type VII Collagen Gene (COL 7 Al) in patients with Recessive Dystrophic Epidermolysis Bullosa. J Invest Dermatol1997;109:246-249.
Shimizu H, McGrath JA, Christiano AM et al. Molecular basis of recessive dystrophic epidermolysis bullosa; genotype/phenotype correlation in a case of moderate clinical severity. J Invest Dermatol 1996; 106:119-124.
Hovnanian A, Rochet A, Bodemer C. et al. Characterization of 18 new mutations in COL 7 A1 in recessive dystrophic epidermolyisis bullosa provides evidence for distinct molecular mechanisms underlying defective anchoring fibril formation. Am J Human Genet 1997;61:599-610.
Salas-Alanis JC. Nace Fundación DEBRA MEXICO AC, Carta al editor, Rev Mex Dermatol1998;42:172-193.
Christiano AM, Hoffman G, Chung-Honet LC et al. Structural organization of the human type VII collagen gene (COL 7 Al) compromised of more exon than any previously characterized gene. Genomics 1994;21:169-179.
Christiano AM, Hoffman GC, Zhang X. et al. A strategy for identification of sequence variants in COL 7 Al, and a novel 2 bp deletion mutation in recessive Dystrophic epidermolysis bullosa, Hum Mutant 1997;10:408-414.
Ganguly A, Rock MJ, Prockop DJ. Conformation-sensitive gel electrophoresis for rapid detection of single-base differences in doublestranded PCR products and DNA fragments; evidence for solvent-induced bends in DNA heteroduplex. Proc Natl Acad Sci USA 1993;90:10,325-329.
Salas-Alanis JC, Mellerio JE, Amaya-Guerra Mario et al,. Frameshift mutations in the type VII collagen gen (COL 7 Al) in five Mexican cousins with recessive Dystrophic epidermolysis bullosa. Br J DermatoI 1998;138:852- 858.
Murata T, Masunaga T, Shimizu H, Nishikawa T. Differences in recurrent COL 7 Al mutations in dystrophic epidermolysis bullosa: ethnic-specific and worldwide recurrent mutations. Arch Dermatol Res 2004.
Cserhalmi-Friedman MB, Mcgrath JA, Mellerio JE, Romero R, Salas-Alanis JC, et al. Restoration of an Open Reading Frame Resulting from Skipping orfan Exon with an Internal Deletion in the COL 7 Al Gene. Lab Invest 1998;78:1483-1492.
Salas-Alanis JC, Mellerio JE, Amaya-Guerra M, et al. Frameshift mutation in the type VII Collagen gene (COL 7 Al) in five Mexican cousinswith recessive dystrophic epidermolysis bullosa. British J Dermatol1998;138:852-858.
Mellerio JE, Salas-Alanis JC, Talamantes ML, et al. A recurrent glycine substitution mutation, G2043R, in the type VII collagen gene (COLA71) in dominant dystrophic epidermolysis bullosa. Br J Dermatol 1998;139:730-737.
McGrath JA, Dunnill MGS, Christiano AM, Lake BD, Atherton DJA, Rodeck CH, et al. First trimester DNA-based exclusion of recessive dystrophic epidermolysis bullosa from chorionic villus sampling. British J of Dermatol 1996;134:734-739.
McGrath JA, Ashton GHS, Mellerio JE, et al. Moderation of phenotype severity in Dystrophic and functional forms of epidermolysis bullosa trough in-frameshift mutations. J Invest Dermatol 1999;113:314-321.